2025-2029 Strategic Plan
Neighbourhood Pharmacies kicked off 2025 by launching our NEW 2025-2029 strategic plan 'Prescription for Success'.
Read more about 2025-2029 Strategic PlanNeighbourhood Pharmacies Raises Concerns with Proposed Pharmacy Staffing Ratio in NS
On November 12, Neighbourhood Pharmacies responded officially to the Nova Scotia College of Pharmacy's open consultation on their draft Pharmacy Staffing Level policy and the planned implementation o…
Read more about Neighbourhood Pharmacies Raises Concerns with Proposed Pharmacy Staffing Ratio in NSNeighbourhood Pharmacies Responds to Ontario Ministry of Finance Consultation on Preferred Provider Networks
- Submission
- Government relations
- Medication Access
- Pharmacy Benefit Managers
- Preferred Provider Network
Neighbourhood Pharmacies has provided a preliminary submission to the Ontario Ministry of Finance in response to their open consultation on Preferred Provider Networks in the Employer-Sponsored Drug …
Read more about Neighbourhood Pharmacies Responds to Ontario Ministry of Finance Consultation on Preferred Provider NetworksNeighbourhood Pharmacies Responds to Consultation on Proposed Changes to Pharmacy Sector
- Submission
- Routine Immunization
- Minor Ailments
- Scope of Practice
- Government relations
- Medication Access
Neighbourhood Pharmacies has responded to the Ontario Government's recent consultation on their proposed changes to the pharmacy sector in the province.
Read more about Neighbourhood Pharmacies Responds to Consultation on Proposed Changes to Pharmacy SectorPharmacare Watch (Volume 24)
Bill C-64: An Act respecting pharmacare is now the law of the land.
Read more about Pharmacare Watch (Volume 24)Pharmacare Watch (Volume 22 & 23)
The Senate’s Standing Committee on Social Affairs, Science and Technology has wrapped up their final two days of witness testimony in the review of Bill C-64.
Read more about Pharmacare Watch (Volume 22 & 23)Pharmacare Watch (Volume 20 & 21)
The first two days of study on Bill C-64 has concluded at the Senate’s Standing Committee on Social Affairs, Science and Technology.
Read more about Pharmacare Watch (Volume 20 & 21)